1 Followers on Owler

PanTher Therapeutics

is a Private company. Laura Indolfi is the Co-Founder & CEO of PanTher Therapeutics. PanTher Therapeutics's latest funding round was a Series A for $5.4M on May 2021. PanTher Therapeutics has 1 followers on Owler.
OverviewFundingNews & Insights

PanTher Therapeutics

is a Private company. Laura Indolfi is the Co-Founder & CEO of PanTher Therapeutics. PanTher Therapeutics's latest funding round was a Series A for $5.4M on May 2021. PanTher Therapeutics has 1 followers on Owler.
PanTher Therapeutics Co-Founder & CEO: Laura Indolfi

Co-Founder & CEO

Laura Indolfi

CEO Approval Rating

- -/100

2014

Private

Pharmaceuticals & Biotechnology
Biotechnology

Est. Annual Revenue
<$1M
Agree?
Est. Employees
<10
Agree?
Funding
$5.4M

News

Jul 09, 2025
Pharmabiz
PanTher Therapeutics: PanTher Therapeutics treats first patient with PTM101 in phase 1b clinical trial in pancreatic ductal adenocarcinoma
Jul 07, 2025
Medical Device Network
PanTher Therapeutics: PanTher Therapeutics launches second trial for chemotherapy patch
Aug 13, 2024
Business Wire
Press Release: PanTher Therapeutics : PanTher Therapeutics Receives FDA Clearance of IND Application for Phase 1b Study of PTM-101 for the Localized Treatment of Pancreatic Cancer
Apr 08, 2024
StreetInsider
Press Release: PanTher Therapeutics : PanTher Therapeutics Presents Positive First-in-Human Data for PTM-101 in Pancreatic Cancer at AACR Annual Meeting
Aug 22, 2022
BioSpace
PanTher Therapeutics: PanTher Therapeutics Awarded $14.2M from CPRIT to Advance Targeted, Localized and Sustained Cancer Treatment
Aug 21, 2022
Acrofan
PanTher Therapeutics: PanTher Therapeutics Awarded $14.2M from CPRIT to Advance Targeted, Localized and Sustained Cancer Treatment
May 23, 2022
Acrofan
PanTher Therapeutics: PanTher Therapeutics Secures Patent for Anticancer Drug-Eluting Stent
Oct 06, 2021
MarketScreener
PanTher Therapeutics: PanTher Therapeutics : Doses First Two Patients in Phase 1 Trial of PTM-101 for Treatment of Pancreatic Cancer
Aug 04, 2021
MarketScreener
PanTher Therapeutics: PanTher Therapeutics : Receives Ethics Approval to Initiate Phase 1 Clinical Trial of PTM-101 in Australia; Announces Appointment of Chief Medical Officer; Establishes Clinical Advisory Board
Jun 20, 2021
FinTech InShorts
PanTher Therapeutics: PanTHer Therapeutics: Closes $5.4M In Series A Funding -

Trending Companies